Repurposing Vitamin D as an Anticancer Drug
- 28 October 2015
- journal article
- Published by Elsevier in Clinical Oncology
- Vol. 28 (1) , 36-41
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Vitamin D–Related Genetic Variation, Plasma Vitamin D, and Risk of Lethal Prostate Cancer: A Prospective Nested Case–Control StudyJNCI: Journal of the National Cancer Institute, 2012
- Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trialsThe Lancet, 2012
- 25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1Breast Cancer Research and Treatment, 2012
- Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?British Journal of Cancer, 2011
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trialsThe Lancet, 2011
- Calcium Plus Vitamin D Supplementation and the Risk of Breast CancerJNCI: Journal of the National Cancer Institute, 2008
- Vitamin D, aging, and cancerNutrition Reviews, 2008
- Calcium plus Vitamin D Supplementation and the Risk of Colorectal CancerNew England Journal of Medicine, 2006
- Noncalcemic Actions of Vitamin D Receptor LigandsEndocrine Reviews, 2005
- Effect of four monthly oral vitamin D 3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trialBMJ, 2003